The market attractiveness of Duodenoscopes remains high, driven by aging populations, expanding endoscopic therapeutic indications, and rising reimbursement rates in mature economies. Competitive intensity is moderate to high; a handful of legacy OEMs dominate volume share while emerging Asian manufacturers accelerate price‑driven entry, prompting margin pressure and strategic partnerships. The long‑term outlook is positive, with CAGR forecasts above 5 % through 2032, underpinned by incremental adoption of single‑use duodenoscopes and integration of AI‑assisted imaging. The innovation landscape is concentrated on disposable device platforms, enhanced ergonomics, and advanced tip navigation, creating a differentiation ladder that rewards R&D investment. Current demand–supply balance tilts toward premium segments, yet the surge in cost‑effective single‑use models is rebalancing the market equilibrium. Key risk factors include regulatory scrutiny over device reprocessing, potential supply‑chain disruptions for high‑precision optics, and macro‑economic volatility that could defer capital‑expenditure programs. Overall, the Duodenoscopes market outlook signals sustainable growth for firms that can navigate compliance, scale innovative pipelines, and optimize cost structures.